Merck says it sold $952 million of COVID-19 treatment pill in 4Q

Feb. THREE (UPI) — Merck stated Thursday it bought $952 million of molnupiravir, its coronavirus remedy pill, over the fourth quarter in 2021 and expects to promote up to $6 billion this 12 months.

The drugmaker highlighted its oral remedy with Ridgeback Biotherapeutics in its fourth quarter and 2021 12 months-end document. The Food and Drug Administration authorized the drug for emergency use in December.


Leave a comment

SMM Panel PDF Kitap indir